相关实验视频

Updated: Jun 29, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

通过调节TGF-β/Smad2信号通路,ACSL4可以加速骨髓瘤的进展

Xiaofeng Li¹, Qianfen Chen¹, Duo Zhao¹

¹Department of Spine and Osteopathy Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China.

Molecular and cellular biochemistry

|April 2, 2024

概括

长链乙-A合成酶家族成员4 (ACSL4) 在骨髓瘤 (OS) 中被上调. 沉默ACSL4通过调节TGF-β/Smad2通路来抑制OS细胞的增殖,迁移和瘤生长.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

骨髓瘤 (OS) 是一种主要的骨癌.
在OS中A-CoA合成酶长链家族成员4 (ACSL4) 的作用尚不清楚.
在各种癌症中,ACSL4被认为是一种瘤基因.

研究的目的:

调查OS中的ACSL4表达.
确定ACSL4在OS细胞增殖,迁移和亡中的生物功能.
阐明 ACSL4 影响 OS 进展的分子机制.

主要方法:

人体组织微阵列的免疫组织化学 (IHC) 染色.
定量实时PCR (qPCR) 分析.
使用ACSL4枯竭细胞系 (MNNG/HOS,U-2OS) 的功能丧失实验.
在体内研究使用皮下异种移植小鼠模型.
西方斑点分析以评估蛋白质酸化 (Smad2).
用TGF-β抑制剂进行治疗.

主要成果:

在OS组织和细胞中,ACSL4的表达显著上调.
ACSL4敲击抑制了OS细胞的增殖,诱导了G2阶段的停止和亡,并抑制了迁移.
在体内,ACSL4沉默对异种移植小鼠的瘤生长有损.
ACSL4调节Smad2酸化,而TGF-β抑制可以抵消ACSL4的瘤效应.
ACSL4通过TGF-β/Smad2信号通路调节骨髓瘤的进展.

结论:

ACSL4是骨髓瘤进展的关键驱动因素.
准ACSL4可能是OS的新疗法策略.
在OS病变发生过程中ACSL4的作用涉及TGF-β/Smad2信号通路.

关键词:

ACSL4 ACSL4 ACSL4 ACSL4 ACSL4 ACSL4 ACS 细胞亡是细胞的亡.细胞的增殖细胞的增殖.骨质肉瘤骨质肉瘤是什么在TGF-β信号通路中.

更多相关视频

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...